keyboard_arrow_up

Ziarco Pharma Ltd Product Pipeline H2 2014 Review Research Report

RnRMarketResearch.com adds “Ziarco Pharma Ltd – Product Pipeline Review – 2014“ report to its research database.

The report “Ziarco Pharma Ltd – Product Pipeline Review – 2014“ provides comprehensive information on the current therapeutic developmental pipeline of Ziarco Pharma Ltd’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Complete Report Details @ http://www.rnrmarketresearch.com/ziarco-pharma-ltd-product-pipeline-review-2014-market-report.html .

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

Purchase a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=248294 .

Scope

- The report provides brief overview of Ziarco Pharma Ltd including business description, key information and facts, and its locations and subsidiaries

- The report reviews current pipeline of Ziarco Pharma Ltd’s human therapeutic division and enlists all their major and minor projects

- The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones

- Special feature on out-licensed and partnered product portfolio

- The report summarizes all the dormant and discontinued pipeline projects

- Latest company statement

- Latest news and deals relating to the Ziarco Pharma Ltd’s pipeline products

Table of Contents

Table of Contents 2
List of Tables 4
List of Figures 4
Ziarco Pharma Ltd Snapshot 5
Ziarco Pharma Ltd Overview 5
Key Information 5
Key Facts 5
Ziarco Pharma Ltd - Research and Development Overview 6
Key Therapeutic Areas 6
Ziarco Pharma Ltd - Pipeline Review 9
Pipeline Products by Stage of Development 9
Pipeline Products - Monotherapy 10
Ziarco Pharma Ltd - Pipeline Products Glance 11
Ziarco Pharma Ltd - Clinical Stage Pipeline Products 11
Phase I Products/Combination Treatment Modalities 11
Ziarco Pharma Ltd - Early Stage Pipeline Products 12
Preclinical Products/Combination Treatment Modalities 12
Discovery Products/Combination Treatment Modalities 13
Ziarco Pharma Ltd - Drug Profiles 14
ZPL-3893787 14
Product Description 14
Mechanism of Action 14
R&D Progress 14
ZPL-5212372 15
Product Description 15
Mechanism of Action 15
R&D Progress 15
Small Molecules to Inhibit Histamine H3 Receptor for Nasal Congestion and Allergic Rhinitis 16
Product Description 16
Mechanism of Action 16
R&D Progress 16
Small Molecules to Inhibit Histamine H4 Receptor for Allergies and Inflammation 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
ZPL-868087 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
Small Molecules to Inhibit Spleen Tyrosine Kinase for Allergic Inflammatory Disorders 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
Ziarco Pharma Ltd - Pipeline Analysis 20
Ziarco Pharma Ltd - Pipeline Products by Target 20
Ziarco Pharma Ltd - Pipeline Products by Route of Administration 21
Ziarco Pharma Ltd - Pipeline Products by Molecule Type 22
Ziarco Pharma Ltd - Pipeline Products by Mechanism of Action 23
Ziarco Pharma Ltd - Recent Pipeline Updates 24
Ziarco Pharma Ltd - Discontinued Pipeline Products 25
Discontinued Pipeline Product Profiles 25
ZPL-3893787 25
ZPL-5212372 25
Ziarco Pharma Ltd - Locations And Subsidiaries 26
Head Office 26
Appendix 27
Methodology 27
Coverage 27
Secondary Research 27
Primary Research 27
Expert Panel Validation 27
Contact Us 28
Disclaimer 28

List of Tables

Ziarco Pharma Ltd, Key Information 5
Ziarco Pharma Ltd, Key Facts 5
Ziarco Pharma Ltd - Pipeline by Indication, 2014 8
Ziarco Pharma Ltd - Pipeline by Stage of Development, 2014 9
Ziarco Pharma Ltd - Monotherapy Products in Pipeline, 2014 10
Ziarco Pharma Ltd - Phase I, 2014 11
Ziarco Pharma Ltd - Preclinical, 2014 12
Ziarco Pharma Ltd - Discovery, 2014 13
Ziarco Pharma Ltd - Pipeline by Target, 2014 20
Ziarco Pharma Ltd - Pipeline by Route of Administration, 2014 21
Ziarco Pharma Ltd - Pipeline by Molecule Type, 2014 22
Ziarco Pharma Ltd - Pipeline Products by Mechanism of Action, 2014 23
Ziarco Pharma Ltd - Recent Pipeline Updates, 2014 24
Ziarco Pharma Ltd - Discontinued Pipeline Products, 2014 25

List of Figures

Ziarco Pharma Ltd - Pipeline by Top 10 Indication, 2014 7
Ziarco Pharma Ltd - Pipeline by Stage of Development, 2014 9
Ziarco Pharma Ltd - Monotherapy Products in Pipeline, 2014 10
Ziarco Pharma Ltd - Pipeline by Top 10 Target, 2014 20
Ziarco Pharma Ltd - Pipeline by Top 10 Route of Administration, 2014 21
Ziarco Pharma Ltd - Pipeline by Top 10 Molecule Type, 2014 22
Ziarco Pharma Ltd - Pipeline Products by Top 10 Mechanism of Action, 2014 23

Browse more reports on Pharmaceuticals Market @ http://www.rnrmarketresearch.com/reports/life-sciences/pharmaceuticals .